Latest
1752vc1752vc|Deviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech StartupsDeviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech Startups|ParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology TherapiesParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology Therapies|DISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer RetentionDISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer Retention|a16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructurea16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructure|Restive Ventures Raises $45M Fund III to Back AI-Native Financial Services StartupsRestive Ventures Raises $45M Fund III to Back AI-Native Financial Services Startups|5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services|Pit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise OperationsPit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise Operations|Lunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure SystemsLunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure Systems|Anagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic FibrosisAnagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic Fibrosis|1752vc1752vc|Deviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech StartupsDeviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech Startups|ParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology TherapiesParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology Therapies|DISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer RetentionDISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer Retention|a16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructurea16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructure|Restive Ventures Raises $45M Fund III to Back AI-Native Financial Services StartupsRestive Ventures Raises $45M Fund III to Back AI-Native Financial Services Startups|5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services|Pit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise OperationsPit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise Operations|Lunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure SystemsLunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure Systems|Anagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic FibrosisAnagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic Fibrosis
Back to articles

AuX Labs Raises $4M to Produce Real Dairy Proteins with Precision Fermentation

The difference between a great slice and a disappointing one isn’t marketing… it’s melt. It’s stretch. It’s that split-second pull that either earns loyalty or kills it. AuX Labs just stepped into that moment with $4M in fresh backing, and now the cheese conversation has teeth.

Toronto-based AuX Labs, led by Founder and CEO Ted Jin, is engineering dairy proteins without the cow in the room. Precision fermentation, engineered yeast, and a quiet obsession with casein, the one protein plant-based cheese has been faking badly for years. Melt, stretch, taste… the holy trinity of pizza credibility. Most alternatives show up looking the part, then fold under heat like a bad poker hand.

This round was led by NYA Ventures, with Nàdarra Ventures stepping in strong and placing Mary Dimou on the board. Verdex Capital and Builders VC joined the table, while Congruent Ventures and Bluestein Ventures doubled down like they’ve seen this movie before and liked the ending. That kind of investor behavior usually means one thing… the data is starting to talk back.

And the numbers whisper something interesting. Protein titers north of 20 g/L. A path toward roughly $10/kg. Self-affirmed GRAS status already in play. Translation… this isn’t a science fair project anymore. This is infrastructure being quietly assembled for a $200B+ global cheese market that still runs on cows and compromise.

The real play here isn’t “alternative.” That word already feels tired. AuX Labs is going straight for equivalence… same performance, different origin. If you can hit melt and stretch without apology, you stop being the backup option and start stealing shelf space like it’s owed to you.

The move now is speed. This capital goes into manufacturing, team expansion, and partnerships where performance actually gets judged… foodservice. Because nobody debates texture harder than a customer staring down a slice that didn’t behave.

There’s a pattern emerging in this market. The winners aren’t trying to convince consumers to change habits. They’re rebuilding the inputs so consumers don’t have to notice. AuX Labs isn’t selling a story. They’re selling physics that finally works under heat.